Adalimumab in the treatment of moderate-severe hidradenitis suppurativa: a cost-effectiveness analysis
Introduction: To assess the cost-effectiveness of adalimumab versus supportive care in the treatment of adults with active moderate to severe hidradenitis suppurativa who have had an inadequate response to or are intolerant of conventional systemic therapy in Portugal. Methods: A Markov model with...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Formifarma, LDA.,
2018-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|